Skip to content

Report highlights major failings in UK response to hepatitis C

High prevalence of oral HPV infection in Dutch gay men

Daclatasvir + asunaprevir + BMS-791352 looks promising as interferon-free combination

Blackmail, violence and stigma restrict access to sexual health services for gay men, Global Health and Rights Study reports

Compassionate access to new hepatitis C drugs an "emergency" for European patients

Second-generation HCV protease inhibitor simeprevir pushes triple therapy cure rate up to 80%

Second-generation protease inhibitor faldaprevir cures up to 80% of hepatitis C

Triple-drug HCV therapy comes with high risk of serious adverse events for people with cirrhosis

Hep C quad regimens quashed, but some components go forward